[HTML][HTML] The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
S Wang, Y Zheng, F Yang, L Zhu, XQ Zhu… - Signal transduction and …, 2021 - nature.com
Pancreatic cancer is an increasingly common cause of cancer mortality with a tight
correspondence between disease mortality and incidence. Furthermore, it is usually …
correspondence between disease mortality and incidence. Furthermore, it is usually …
The multifaceted role of autophagy in cancer
RC Russell, KL Guan - The EMBO journal, 2022 - embopress.org
Autophagy is a cellular degradative pathway that plays diverse roles in maintaining cellular
homeostasis. Cellular stress caused by starvation, organelle damage, or proteotoxic …
homeostasis. Cellular stress caused by starvation, organelle damage, or proteotoxic …
Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
CM Sousa, DE Biancur, X Wang, CJ Halbrook… - Nature, 2016 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease characterized by an
intense fibrotic stromal response and deregulated metabolism,,,. The role of the stroma in …
intense fibrotic stromal response and deregulated metabolism,,,. The role of the stroma in …
The enhancement of glycolysis regulates pancreatic cancer metastasis
J Yang, B Ren, G Yang, H Wang, G Chen, L You… - Cellular and Molecular …, 2020 - Springer
Pancreatic ductal adenocarcinoma is prone to distant metastasis and is expected to become
the second leading cause of cancer-related death. In an extremely nutrient-deficient and …
the second leading cause of cancer-related death. In an extremely nutrient-deficient and …
[HTML][HTML] Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors
A Vaziri-Gohar, J Cassel, FS Mohammed, M Zarei… - Nature Cancer, 2022 - nature.com
Nutrient-deprived conditions in the tumor microenvironment (TME) restrain cancer cell
viability due to increased free radicals and reduced energy production. In pancreatic cancer …
viability due to increased free radicals and reduced energy production. In pancreatic cancer …
Pancreatic cancer biology and genetics from an evolutionary perspective
A Makohon-Moore, CA Iacobuzio-Donahue - Nature Reviews Cancer, 2016 - nature.com
Cancer is an evolutionary disease, containing the hallmarks of an asexually reproducing
unicellular organism subject to evolutionary paradigms. Pancreatic ductal adenocarcinoma …
unicellular organism subject to evolutionary paradigms. Pancreatic ductal adenocarcinoma …
Undermining glutaminolysis bolsters chemotherapy while NRF2 promotes chemoresistance in KRAS-driven pancreatic cancers
S Mukhopadhyay, D Goswami, PP Adiseshaiah… - Cancer research, 2020 - AACR
Pancreatic cancer is a disease with limited therapeutic options. Resistance to
chemotherapies poses a significant clinical challenge for patients with pancreatic cancer …
chemotherapies poses a significant clinical challenge for patients with pancreatic cancer …
[HTML][HTML] Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism
Pancreatic ductal adenocarcinoma is a notoriously difficult-to-treat cancer and patients are
in need of novel therapies. We have shown previously that these tumours have altered …
in need of novel therapies. We have shown previously that these tumours have altered …
[HTML][HTML] Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy
Pancreatic ductal adenocarcinoma (PDAC) is considered to be a highly immunosuppressive
and heterogenous neoplasm. Despite improved knowledge regarding the genetic …
and heterogenous neoplasm. Despite improved knowledge regarding the genetic …
Genetics and biology of pancreatic ductal adenocarcinoma
With 5-year survival rates remaining constant at 6% and rising incidences associated with
an epidemic in obesity and metabolic syndrome, pancreatic ductal adenocarcinoma (PDAC) …
an epidemic in obesity and metabolic syndrome, pancreatic ductal adenocarcinoma (PDAC) …